cell signals. Alternatively, the preferential T cell enhancement of IgG~ synthesis may be a result of IgG2a isotype-specific T cells. These T ceils may not affect the entire TNP-Ficoll-responsive clone per se, but rather, may selectively interact only with membrane IgG~-positive cells generated during the response. This interaction with IgG~a-positive daughter cells could conceivably cause an expansion in their number or perhaps in their rate of Ab secretion.
In this report we substantiate the hierarchical order of IgG class expression in responses of nude mice to TNP-FieolI, confirm the preferential effect of T cells at enhancing TNP-Ficoll-induced IgG2a production, and provide evidence that supports the hypothesis that T cells manifest this effect by providing accessory signals that increase switching events within TNP-Ficoll-responsive B cell clones.
Materials and Methods
Animals. C57BL/10 ScN nu/nu, C57BL/10 ScN nu/+, C57BL/10 SeN +/+ mice, and C57BL/KaLwN +/+ were obtained from the Small Animal Section, Division of Research Services, National Institutes of Health, Bethesda, MD. Mice were generally used at 2-3 mo of age.
Antigens. Trinitrophenyl-aminoethylcarbamylmethyl (TNP-AECM)-FicoI1, which will be abbreviated TNP-FieoI1, (tool wt = 400,000; 55 tool TNP/mol Fieoll) was purchased from Biosearch (San Rafael, CA). This was used in all experiments other than the splenic focus assay. TNP-AECM-Fieoll (28 mol TNP/mol Ficoll), a gift of Dr. Alfred Singer, National Cancer Institute, National Institutes of Health, was used in the latter assay. Trinitrophenylatedbovine serum albumin (TNP-BSA) at conjugation rati0~ of 5.1 mol TNP/mol BSA and 10.2 mol TNP/mol BSA were prepared by a modification of the method of Rittenberg and Amkraut (13) , in which various concentrations of trinitrobenzenesulfonic acid (Pierce Chemical Co., Rockford, IL) were reacted with a given amount of BSA.
Selective Enrichment for B or T Cell Preparations.
To enrich selectively for B cells for use in the splenic focus assay (described below), nu/+ spleen cell populations were processed in the following manner. Erythrocytes, dead cells, and Thy-1.2-positive cells were removed by procedures previously described (7) . The cells were then treated with a monoclonal arsanilateconjugated anti-Lyt-1 reagent (Becton, Dickinson & Co., Sunnyvale, CA) at a concentration of 10/zg purified Ab/3-4 x 10 e cells per ml for 30 rain at room temperature (RT), centrifuged, and incubated with rabbit (R) anti-arsanilate (Becton, Dickinson & Co.) at a concentration of 16-20/xg purified immunoglobulin/3-4 X 10 e cells per ml for an additional 30 min at RT. The cells were again centrifuged and finally incubated in a 1:20 dilution of preselected R complement (C) at a cell concentration of 3-4 X 106 cells/ml at 37°C for 45 min. The final viable lymphocyte yield after the anti-Thy-l.2 and anti-Lyt-1 cytotoxic procedures was ~30% of the starting population.
To enrich selectively for T cells, spleen cell suspensions were processed by the method described by Mage et al. (14) , which has been used previously by this laboratory (7) . T cell preparations 'to be used in the splenic focus assay were taken through an additional step to remove potential contaminating B cells, i.e., they were treated with a 1:2 dilution of culture supernatant from a hybridoma-secreting anti-ThB. This reagent recognizes a determinant present on most B cells but not on mature T cells (15) and was kindly donated by Dr. John Kung, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID, NIH). Cells were incubated with anti-ThB at a density of 3-4 X 106 cells/ml for 30 min at RT and then with a 1:20 dilution of R C at 37°C for 45 min. The viable lymphocyte yield after goat anti-Ig-coated plate treatments (twice) and an anti-ThB and C treatment was typically 15-18% of the starting population.
RIA for the detection of antibody produced by secretory cells has been described by us elsewhere (16) . Briefly, cells are cultured on TNP-BSA-precoated flexible flat-bottomed microtiter wells for 24 h at 37°C in a humidified 5% CO2 atmosphere. Various numbers of immune cells were always tested to insure that a dose was obtained in which secreted antibody did not saturate the binding capacity of the antigen-coated wells. After 24 h of culture, the cells were washed away and the amount of bound anti-TNP Ab was measured with the use of all-labeled antiisotype reagents.
3H-labeled Anti-Isotype Reagents. The production of the various classes of anti-TNP Ab was quantitated with the use of affinity-purified anti-isotype reagents (anti-IgM, anti-IgG1, antiIgG~a, anti-IgG~, and anti-IgGa) which had been tritiated with NaBnI-h as described previously (7, 17) .These reagents have been shown to be specific and to have comparable binding efficiencies for their respective insolubilized Ig class substrates (7) . Because of their comparable binding efficiencies, we have considered it legitimate to compare binding titers (in our serum analyses) from one isotype to another, and to compare percentage-bound values (in our in vitro secretion analyses) from one isotype to another.
In our RIA for soluble Ab, the [3H]anti-IgGa and the [aH]anti-IgG2b reagents are both capable of detecting a minimum of ~0.2 ng/ml of purified monoclonal anti-TNP Ab of the IgG1 and IgC,,2b isotypes, respectively (I 6). Because all the anti-isotype reagents have comparable binding efficiencies, the sensitivity of the RIA for detection of anti-TNP Ab of other classes when the anti-IgM, anti-IgG3, and anti-IgG~ reagents are used is likely also to be ~0.2 ng/ml.
Assay for Relative Affinities of Anti-TNP Antibodies. Herzenberg et al. (18) have recently described a method to assess Ab affinity. In this technique the ability of an Ab to bind wells coated with TNP-BSA of a relatively low degree of conjugation is compared with its ability to bind to wells coated with TNP-BSA of a higher degree of conjugation. We compared the affinities of various monoelonal anti-TNP reagents and anti-TNP sera by analysis of their TNPn.x-BSA/TNP10.~-BSA binding ratios. Briefly, the microtiter wells were coated for 1 h with 50 ~1 of TNP6a-BSA or TNPlo.2-BSA in saline at a concentration of 100 p,g/ml, washed, and incubated with 50 #1 of various dilutions of anti-TNP Ab in phosphate-buffered saline, pH 7.4 (PBS) + 1% BSA + 0.1% sodium azide + 0.005 M disodium ethylenediamine tetraacetate (assay buffer) for ~ 1-2 h. The wells were then washed, and 50 #1 (~30,000 cpm) of the appropriate nil-labeled anti-isotype reagent in assay buffer was added to each well. After ~2 h of incubation, the wells were washed again and the amount of anti-TNP Ab bound specifically to the wells was analyzed by measuring the counts per minute of the 3H-labeled anti-isotype reagent bound. Binding curves were established by plotting the log of the counts per minute bound by the log of anti-TNP Ab dilution tested. The ratio of TNPsa-BSA/TNPlo.2-BSA binding was obtained by comparing the counts per minute bound at a given dilution within the linear region of the binding curves.
The purified MOPC-315 and MOPC-460 IgA myeloma proteins used in these assays as monoclonal standards were kindly provided by Dr. Abdulla Rifai (University of Washington Medical School, Seattle, WA) and Dr. Constantin Bona (Mount Sinai School of Medicine, New York), respectively. The monoclonal anti-dinitrophenyl (DNP) hybridoma Ab designated as 3-12-D (IgG1) and 6-16-A (IgG1) were generated by M. Scott and Dr. J. Fleischman (Washington University Medical School, St. Louis, MO) were previously studied (17) and were provided to us by Dr. Leonore Herzenberg (Stanford University Medical School, Stanford, CA).
The reported affinities of these various reagents are MOPC-315, Ka = 2 X 107 L/M for TNP (19) ; MOPC-460, Ki = 1.2 × 105 L/M for TNP (20) ; 3-12-D, K, = 1.0 × 106 L/M for DNP (18) ; and 6-16-A, Ka ---1.1 X l0 s L/M for DNP (18) . In a comparison of the relative binding of the 3-12-D and 6-16-A reagents to wells coated with TNP-BSA vs. DNP-BSA, the 3-12-D hybridoma protein exhibited a much higher affinity for DNP than for TNP. The 6-16-A reagent, however, bound DNP and TNP to a comparable degree (P. Mongini, unpublished data).
Anti-IgM Treatment of Neonatal Mice. Anti-IgM to be used for this procedure was prepared in the following manner. Goat anti-Mc471B (anti-IgM, i¢ BALB/c myeloma protein, a kind gift of Dr. Richard Asofsky, NIAID, NIH) was passed over CBPC-101-(IgGz,, x) and MOPC-195S-(IgG2b, i¢) Sepharose affinity columns to remove anti-Fab and anti-IgG activity from the immune serum. The nonbound serum fractions were then precipitated three times with 50% saturated (Nt-h)2SO4 (vol:vol) at 4°C, dialyzed in PBS, centrifuged at 15,000 rpm for 30 rain to remove aggregates, and sterilely filtered. A rough analysis of Ab activity was performed by comparing the ability of various concentrations of this preparation and of affinity-purified antiIgM protein derived from this preparation (prepared by Dr. Anthony DeFranco, NIAID, NIH) at precipitating TEPC-183 in gel diffusion. 0.5 mg/ml of the (NHi)zSO4-precipitated preparation gave as strong a preeipitin line as 0.125 mg/ml affinity-purified goat anti-IgM. Thus, we can estimate that approximately one-fourth of the protein in this preparation is anti-IgM.
For anti-IgM treatment, neonatal C57BL/10 mice were injected intraperitoneally with 0.1 ml (1.6 rag) of the above preparation within 12 h of birth. This treatment was continued daily for the first week; every other day thereafter the mice were given 0.15 ml (2.4 mg) intraperitoneally until they were killed at 2 mo of age. When they had been killed the mice were found, by gel-diffusion analysis, to have anti-IgM in their serum and to have no detectable serum levels of IgM. The spleens of these mice were found to have 3% Ig + cells, whereas untreated age-matched C57BL/10 mice had 30% Ig + cells in their spleens as determined by fluorescence microscopy.
Splenic Focus Assay for Enumeration of Anti-TNP-Ficoll-responsive Clones.
A modification of the splenic focus assay described previously (21, 22) was used to analyze the isotypes produced by TNP-Fieoll-responsive B cell clones. Briefly, limiting numbers of unprimed B cells with or without a given number of unprimed T cells were transferred intravenously into lethally irradiated unprimed recipients. To insure the complete absence of thymus-matured T cells, the recipients used were 1,600-rad 137Cs-irradiated C57BL/10 SeN nu/nu mice. Approximately 15 h after cell transfer, the recipients were injected with 10 #g TNP-AECM-Ficoll intravenously and after 1 h were killed, and splenic fragments prepared and placed into culture. Culture supernatants were changed every 3-4 d. 8upernatants from days 7 through 17 were tested for anti-TNP antibody of the various isotypes by the RIA described above.
A preliminary analysis of the relationship of B cell dose to number of positive fragments was consistent with our data following a Poisson distribution (23) . We have used a dose of 2.5-5 × 106 B cells per recipient. This dose allowed us to maintain the frequency of total positive fragments <27% and yet to measure the frequency of very infrequently produced Ab isotypes, e.g., IgGh, without expanding the number of fragments tested to an unmanageable size.
In the splenic focus assay we were concerned with the positivity or negativity of a given fragment for the production of a given isotype ofanti-TNP Ab. The cutoffin counts per minute anti-isotype bound which was used to categorize supernatants as positive or negative in our RIA was determined in two ways: (a) by calculating the X ± 3 SD of the counts per minute bound in all splenic fragments from mice given B cells only (no antigen) or B and T cells (no antigen), and (b) by constructing a histogram of the percentage of fragments (from mice which received cells and antigen) that fall into ascending counts per minute-bound categories and determining the point at which a trough in the bimodal distribution of positive and negative fragments appeared (24) . In general, the cutoff point for positivity was the same with both of these approaches. Table   I demonstrate our recently described observation that T cells can exert what appears to be an IgG subclass-specific effect on the antibody response to the TI-2 antigen, TNP-FieolI. When the anti-TNP-Ficoll serum responses ofnu/nu and syngeneic T cell reconstituted nu/nu mice were compared, it was found that T cells caused a preferential enhancement of the IgG~ and IgG2b responses; the Ig~a response was increased to a more significant degree than the IgCmb response. However, the IgGa, IgGn, and IgM responses were not substantially different between the two groups of mice. in addition, this experiment illustrates the highly reproducible isotype hierarchy seen when the quantities of serum Ab of the various classes produced in nonreconstituted nude mice are compared, i.e., IgM > IgG3 > IgG1 > IgG2b > IgG2a. microtiter wells for 24 h at 37°C. The cells were then washed away and the amount of each isotype bound to the wells quantitated by the addition of-30,000 cpm of 3H-anti-IgM, aH-anti-IgGa, SH-antiIgGl, SH-anti-Ig~b, and SH-anti-IgG~ to the appropriate wells. Spleen cells from groups of mice immunized 5, 7, 9, 11, and 13 d previously were tested. The data shown in the peak response of each class of Ab. Each value is the X ± SE of spleen cells from three individual mice.
Results

Preferential T Cell Enhancement of IgG~ Ab Response to TNP-FicolL The data in
To exclude the possibility that this isotypic hierarchy resulted from differing rates of in vivo immunoglobulin clearance, we have compared the in vitro secretion of Ab from spleen cells of immune nu/nu or T cell-reconstituted nu/nu mice. Table II presents data from an experiment in which the in vitro secretion of Ab from spleen cells of mice immunized 5, 7, 9, 11, and 13 d previously with TNP-Ficoll was analyzed. The results shown are the peak amounts of anti-TNP Ab of each isotype produced. The results confirm the isotypic hierarchy observed when serum Ab levels were analyzed and eliminate the possibility that the differences in the serum levels of various classes of anti-TNP-Ficoll Ab were due to differences in in vivo clearance rates.
In addition, the in vitro spleen cell secretion data presented in Table II confirm the preferential relative enhancement of IgG2, Ab synthesis by T cells. These data indicate that T cells can occasionally cause an enhancement in other IgG subclasses as well. Interestingly, the relative enhancement of each of the isotypes by T cells inversely correlates with the relative synthesis of each of the isotypes in the absence of added T cells. In the numerous experiments in which serum responses have been analyzed, the * This RIA was performed and the binding ratios calculated as described in Materials and Methods. In Exp. 1, the binding ratios of individual sera from a group of TF-immune mice were analyzed; results are shown as X ± SE. In the remaining experiments serum pools from immune mice were tested. $ The Ka of 3-12-D and 6-16-A for TNP were not available; however, the Ka of 3-12-D and 6-16-A for DNP have been reported to be 1.0 × 106 and 1.1 × l0 s, respectively. As a result of comparing the binding of these monoclonal proteins to DNP4~-BSA and TNPls-BSA we concluded that 3-12-D binds TNP with much less affinity than DNP and that 6-16-A has approximately the same binding affinity for TNP and DNP.
enhancement of IgGn and IgG1 responses by T cells has been occasionally observed but is not a reproducible phenomenon. The enhancement of the IgG2 responses, most notably the IgG~ response, has been consistently observed.
Comparison of the Affinities of IgGza Anti-TNP-Ficoll Ab in nu/nu and in T Cell-reconstituted nu/nu Mice.
We wished to exclude the possibility that the preferential T cell effect on IgG2a Ab synthesis might be a result of changes in the IgG2a antibody's affinity for antigen rather than in the antibody's concentration. This was a potential concern because high affinity Ab might be more easily detected in the RIA we employed. Therefore, we compared the relative affinities of IgG2~ anti-TNP-Ficoll Ab produced by nu/nu and T cell-reconstituted nu/nu mice by assessing their differential binding to wells coated with TNP-BSA of varying degrees of conjugation (18) . The data in Table  III show that in this assay, which is capable of distinguishing a range of equilibrium constants from 105 L/M to >107 L/M, no significant difference in the TNPs-BSA/ TNP10.2-BSA binding ratio of IgG2~ Ab from nu/nu or T cell-reconstituted nu/nu mice could be discerned. Thus, we have found no indication that T cells change the affinity of the IgG2, Ab synthesized to TNP-FieolI. We are, therefore, reasonably certain that the preferential increases in IgG2~ anti-TNP Ab detected by our RIA are a result of increases in IgG2a synthesis.
Ability of T Cells to Enhance the Frequency of TNP-Ficoll-responsive B Cell Clones that Secrete
IgGza. How does the T cell preferentially enhance IgG2~ synthesis in the B cell response to the TI-2 antigen TNP-FicolI? We have previously proposed two possible explanations for this phenomenon: (a) IgG~a isotype-specific T cells may specifically interact with B cells which bear membrane IgG2~ and cause their selective expansion or increase in Ab secretion, or (b) T cells of an as yet undefined specificity may affect the activation or expansion of TNP-Ficoll-responsive B cell clones and thereby increase the frequency with which these clones switch to IgG2~. In an attempt to distinguish between these two possibilities, we have analyzed the effect of T cells upon the TNP-Ficoll response of individual B cell clones. Through the use of a modification of the splenic focus assay (21, 22) , we have compared the isotypes of Ab produced by individual B cell clones in response to TNP-Ficoll in the absence of thymus-matured T cells and in the presence of defined numbers of T cells. If T cells influence IgG2a production in the intact animal by increasing the likelihood that a TNP-Ficoll-responsive B cell clone will switch into IgGza production, then a higher frequency of anti-TNP IgG~-secreting fragments should be observed in the presence of T cells than in their absence. If, on the other hand, T cells, e.g., IgG~ isotype-specific T cells, simply enhance the amount of IgG2a Ab produced in clones that had by a T-independent mechanism switched into IgG2a production, then one might expect to find equivalent numbers of IgG2a-secreting fragments in the presence or absence of T cells; T cell-containing fragments would be expected to have a higher concentration of IgG~. It should be noted that the above comparison would only be valid if the frequency of TNP-Ficoll-responsive clones that produce IgG2a in the absence of T cells is substantially less than the frequency of all TNP-Ficoll-responsive clones.
The basic protocol used in the TNP-Ficoll splenic focus assay was as follows: 2.5-5 X l0 s purified B cells were transferred into 1,600-rad-irradiated nu/nu recipients with or without 5 × 106 purified syngeneic T cells. 18 h later the recipients were injected with 10/~g TNP-Ficoll intravenously. 1 h after antigen injection, the spleens were excised, sliced into 1-mm fragments, and cultured individually. The frequency of fragments secreting anti-TNP Ab of the IgM, IgGa, IgG1, IgG2u, and IgG2, isotypes after 7-17 d of culture is shown in Table IV. In the absence of T cells, the hierarchy in isotype frequency is again consistent with the 5' to 3' Igh-C gene order. Although T cells appeared to have no significant effect on the number of fragments secreting IgM, IgGz, or IgG1 anti-TNP Ab, the presence of T cells significantly increased the number of fragments secreting detectable IgG2b and IgGz~ Ah. Again, the IgG2~ response was most affected by the presence of T cells. Indeed, in the absence of T cells, only 1 IgG2a-positive clone was observed out of a total of 496 fragments analyzed. That T cells enhanced the production of IgG~ from purified syngeneic nu/+ B cells in the splenic focus assay shows that the enhancement of IgG2~ anti-TNP-Ficoll Ab in We cannot be certain that every TNP-Ficoll-responsive precursor was receiving optimum T cell help in this splenic focus assay. When greater numbers ofT cells were transferred into irradiated nu/nu recipients together with a constant number of B cells, suppressive effects appeared to manifest themselves (data not shown). This is consistent with our previous observation that transfer of >2.5 × 106 T cells into nonirradiated nu/nu mice failed to increase the IgG~, response to TNP-Ficoll above that seen in recipients of 2.5 × l0 s T cells. In fact, the IgG~ response of nudes given -->5 × l0 s T cells was somewhat lower than that of nudes given 2.5 × 10 e T cells (7) .
It is possible that due to the limit in sensitivity of our RIA we have failed to detect fragments that secreted very low levels of IgG~ anti-TNP Ab. The difference in IgG2a production between fragments containing only B cells and those containing B and T cells may therefore be a quantitative rather than qualitative one. We cannot completely rule this out, but we think that it is unlikely for the following reasons. If one assumes a constant secretion rate of 1,000 molecules/cell/s (21, 25) over the course of 3 d of culture, i.e., the interval since the last change in culture supernatant, then a single IgG~-positive secretory cell should have released enough Ab into the culture supernatant to achieve a concentration of 0.07 ng/200 #1 of supernatant, a concentration which our assay is able to measure. We should, therefore, be able to detect approximately one actively secreting cell. However, because this concentration is at the borderline of the sensitivity of the RIA, and because cells may differ in their secretion rates from the above calculated value, we may conceivably have missed some clones that contain very few IgG2a-secreting daughter cells.
With the above caveat, the results from the splenic focus assay indicate that T cells present within fragments containing individual TNP-Ficoll-responsive B cell precursors cause an increase in the number of IgG~-secreting clones rather than simply an increase in the amount of IgGza secreted by positive clones.
Analysis of the Heterogeneity of Isotype Expression within TNP-Ficoll-responsive B Cell
Clones. To achieve a clearer understanding of the switching events that occur within TNP-Ficoll-responsive B cell clones in the presence or absence of T cells, we have analyzed the heterogeneity of isotype expression within the TNP-Ficoll-responsive fragments. This further analysis of the splenic focus assay results is shown in Tables V-VII and in Fig. 1 . Table V Table V . The fragments secreting anti-TNP Ab are categorized as those secreting IgM, IgG3, IgG1, IgG2b, or IgG2a isotypes. The percentage of these fragments that secretes only the designated isotype or which also secretes one to four other isotypes was evaluated. The data again show that fragments that contained B and T cells exhibited a significant increase in the frequency of TNP-Ficoll responsive clones which synthesized all five classes of anti-TNP Ab. This is largely accounted for by the increase in IgG2a expression. Furthermore, the data show that in terms of complexity of isotype expression, fragments secreting IgG~a tend to secrete most of the other isotypes whereas fragments secreting IgM tend to secrete, on the average, fewer additional isotypes. From a probability analysis of our data, it is possible that the co-expression of the more frequently occurring isotypes (i.e., IgM and IgG3) may, in a minority of fragments, be a result of overlap of two independently assorting precursors. However, the possibility that co-expression of the less frequently occurring isotypes results from precursor overlap is highly unlikely.
When co-expression of the various isotypes is analyzed, the following trend is observed: fragments secreting isotypes encoded by genes on the 5' end of the Igh-C gene cluster (5' Igh-p, Igh-y3, Igh-yl, Igh-y2b, Igh-T2a 3') tend, on the average, to be less heterogeneous in terms of expression of other isotypes, whereas fragments secreting isotypes encoded by genes on the 3' end of the Igh-C gene cluster tend to be the most heterogeneous in terms of isotype expression. The data in Fig. 1 and Fie. 1. Analysis of the isotype heterogeneity of the anti-TNP-Ficoll response in fragments containing B + T cells.
secrete IgG2a. Most of the IgGsb-positive fragments secrete IgM and IgG3; however, only 55% also secrete IgG1. The failure of almost half of the IgGsb-secreting fragments to secrete detectable IgG1 is clearly an exception to the trend that fragments secreting a given isotype will also secrete isotypes encoded by 5' Igh-C genes. However, in agreement with the noted trend, most of the IgGsa-positive fragments also secrete IgM, IgGs, IgG1, and IgG2b Ab. Whereas Fig. 1 presents the data as the percent of fragments secreting a defined class of Ab which also secretes a given other isotype, Table VII presents an analysis of the frequency of co-expression of all the 5'-encoded isotypes or all the 3'-encoded isotypes in fragments secreting a defined class of Ab. This comparison clearly shows that there is a higher frequency of co-expression of all the studied 5'-encoded Ig classes (26) given refers to the association of expression of the designated isotype with the co-expression of all other isotypes encoded by 5' lgh-7 genes. In each case this association is highly significant (P << 0.001).
than co-expression of all the studied 3'-encoded isotypes. The X 2 statistic of association of the expression of the designated isotype with the co-expression of all other 5'-encoded isotypes is, in every case, highly significant. It can be noted that not every fragment which secretes a given class of Ab also secretes all the 5'-encoded isotypes, there are exceptions to the trend. Analysis of these variants showed no consistent lack of production of a particular Y-encoded isotype, with the exception of IgG1 coexpression in IgG2b-secreting clones. It is possible that, in these variant clones, switches to the nonsecreted isotype gene were very transient or else randomly bypassed. That anti-TNP Ab of the IgG2a subclass is almost entirely found in fragments that secrete IgM as well as most of the other classes of Ig strongly suggests that most IgG2a-positive fragments arise from IgM-positive precursors and that clones that switch into IgG2~ production have, in the course of their expansion, also switched into production of the other 5'-encoded isotypes.
Early Requirement for T Cells for Optimum lgG~ Enhancement. The data obtained from the splenic focus assay are compatible with the hypothesis that the preferential T cell enhancement of IgG2~ Ab synthesis to TNP-Ficoll is mediated by an amplification of the isotype-switching mechanism within B cell clones. This is based on the observations that T cells increase the frequency of B cell clones that secrete IgG2~ and that IgG2~-positive clones appear to be actively switching clones, i.e., clones that have produced IgM as well as all or nearly all other IgG subclasses. Nevertheless, our observations do not exclude the possibility that the preferential enhancement of IgG2~ synthesis to TNP-Ficoll is mediated by IgG~, isotype-specific T cells that act on B cells that have, by a T-independent mechanism, previously switched into IgG~ production. It is possible that switches to IgG2a occur with equivalent frequency in the presence or absence of T cells but that IgG2~ isotype-specific T cells are required for the initiation of IgG~ secretion from membrane IgG2a-positive cells. We have, therefore, taken two additional approaches to test for possible involvement of IgG~ isotype-specific T cells.
Since IgG-positive daughter cells of antigen-specific precursors do not appear until 
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several days after immunization (27) , we predicted that IgG~-specific T cells would be unable to exert their helper effect until several days after the commencement of the response. Thus, isotype-specific T cells might be expected to function equally well when transferred 1 d before antigen (as in previous experiments) or up to several days after antigen. Fig. 2 shows the data from an experiment in which comparisons were made of the ability of T cells to enhance IgG~ synthesis when transferred at various times before or after antigen. Significant enhancement of the IgG2a response was obtained only when T cells were transferred 1 d before immunization (data from another experiment indicates that T cells are also effective when transferred at the same time as antigen; data not shown). Transfer ofT cells from 1 to 13 d after antigen was administered failed to significantly enhance the peak IgG2a response above that measured in nonreconstituted nu/nu mice.
Ability of T Cells from NeonataUy Anti-IgM-suppressed Mice to Enhance TNP-Ficoll-induced IgG~a Synthesis.
A number of reports have suggested that immunoglobulin-specific T cells are absent in mice whose immunoglobulin production has been suppressed by treatment with anti-IgM since birth (28) (29) (30) . To determine whether the T cell responsible 7or enhancing IgG2a Ab synthesis to TNP-Ficoll might share this property, we compared the ability of T cells from normal or from neonatally anti-IgMsuppressed mice to enhance the IgG2a production of nu/nu mice to this antigen. The data in Table VIII clearly show that purified T cells from anti-IgM-suppressed mice were as efficient at enhancing IgC~ synthesis as normal T cells.
Discussion
In this report we have shown that the athymic nu/nu mouse response to the TI-2 antigen, TNP-Ficoll, is characterized by a distinct hierarchy of Ab production of IgM and the various IgG subclasses. This hierarchy was evident after (a) analysis of serum levels of the various isotypes of anti-TNP Ah, (b) quantitation of the in vitro secretion of Ab from in vivo immunized spleen cells, and (c) measurement of the frequency of TNP-Ficoll-responsive B cell clones that secrete Ab of the various isotypes in a splenic focus assay. An analysis of the plaque-forming cell response of normal euthymic mice to TNP-Ficoll by Slack et al. (31) is consistent with this isotypic order. The isotypic hierarchy we have observed is of particular interest because it directly correlates with the 5' to 3' lgh-C gene order (5' lgh-#, lgh-73 , lgh-yl, Igh-y2b, lgh-y2a 3') (9, 10) and suggests that the position of a given lgh-y gene on the chromosome may influence the rate at which switching to that gene may occur in a B cell clone that responds to TNP-Ficoll. In addition, we have further confirmed our previous observation (7) that T cells can preferentially enhance, in relative terms, IgG~, antibody synthesis to TNPFicoll and can thus sometimes alter the intrinsic isotypic production hierarchy characteristic of this type 2 antigen. Two major explanations exist for the preferential T cell enhancement of IgG2a Ab synthesis to TNP-FicolI. The enhancement of IgG2a Ab synthesis may be attributed to IgC~ isotype-specific T ceils that selectively expand the proliferation or the secretion rates of TNP-Ficoll-specific clonal progeny which have already switched to IgG2a. Alternatively, T cells of yet undefined specificity, may simply enhance the switching process within stimulated B cell clones. Thus, they may preferentially encourage the switch of clonal progeny into those genes, e.g., lgh-y2a, which are located the furthest downstream from the switching region 5' to the Igh-l~ gene (11, 12) and which may have a low probability of being switched to in the absence of T cell signals.
The data presented are more in keeping with the hypothesis that T cells preferentially increase IgG~ anti-TNP-Ficoll Ab production through an enhancement of the switching process. The evidence supporting this hypothesis is best understood by first analyzing the repertoire of isotypes produced in individual B cell clones responding to TNP-FicolI. Results from the splenic focus assay demonstrate that the majority of clones secreting IgG isotypes also secrete IgM. These findings strongly suggest that most of the clones that secrete multiple isotypes probably originated from a single IgM-positive precursor. This is consistent with the observation that B cells that produce IgG after lipopolysaccharide (LPS) stimulation originate from IgM precursors (32, 33) . Since in the B cell response to TNP-Ficoll in the absence of T cells the hierarchy in quantitative production of the various IgG subclasses and the frequency of clones secreting each of these isotypes follows the 5' to 3' lgh-C gene order, it is tempting to conclude that, within an expanding B cell clone derived from a single IgM-positive precursor, switches to lgh-7 genes located the greatest distance downstream from the lgh-# gene may have lower probabilities of occurring than switches to more proximal 1gh-7 genes. Furthermore, the observation that clones that produce IgG2a have produced all or nearly all of the other IgG isotypes suggests that switches to the most distal Igh-y gene, Igh-72a , are preceded or accompanied by switches to all of the 5'-encoded Igh-7 genes. In fact, the trend in our data has shown that clones that switch into the production of any given IgG isotype tend to secrete 5'-encoded isotypes with a much higher frequency than 3'-encoded isotypes. These results do not necessarily imply the occurrence of sequential switching events within a lineage of daughter cells (34) . They could as easily be explained by single # ~ 3'3, # --* yl, bt ~ y2b, and /~ ~ y2a switches occurring within separate daughter cells of a clone. The statistical incidence of each of these switches might be influenced by the length of DNA over which such gene rearrangements must occur.
Our observations that T cells enhance predominantly the in vivo production of those isotypes which, in the absence of T ceils, are produced in the lowest amounts in itself suggested that T cells may increase the frequency of lgh-C gene switches which, in the absence ofT cells, have low incidence of occurrence. This conclusion is strongly supported by the observation that T cells can significantly increase the frequency of B cell clones which produce IgGzb and IgG2a to TNP-Ficoll in the splenic focus assay. Since IgGz-positive clones appear to be clones which are actively switching, it is very likely that T cells that increase the frequency of IgG2-positive clones do so by enhancing the ability of B cell clones that are already switching to the Igh-y3 and lgh-yl genes to also switch downstream to the lgh-y2b and the Igh-y2a genes. This interpretation is compatible with the recent observations by Martinez-Alonso et al. (35) , which suggest that T cells can cause a 5' to 3' directional switch in isotype expression within a mitogen-stimulated B cell population.
Contrary to the evidence consistent with T cell enhancement of the switching process, we have found no evidence in support of IgG2a-isotype-specific T cells. The evidence against them is indirect but is as follows: (a) Mice that have been suppressed in Ab production by treatment with anti-IgM since birth have T cells that can enhance IgG2a Ab synthesis. In contrast, a number of other reports have shown that putative Ig-specific T cells are absent in anti-IgM suppressed mice (28) (29) (30) . Manuscript in preparation). Thus, if the T cell is IgG2~ specific, it is not specific for allotypic determinants, as is the IgGz~-specific helper T cell observed by Herzenberg et al. (5) . (d) Although T cells predominantly affect the production of IgG2a, they can also somewhat affect the production of other subclasses. This lack of an absolute specificity does not favor the existence of a unique IgG2a-isotype-specific helper T cell.
In summary, we feel that the bulk of our observations supports the hypothesis that syngeneic unprimed T cells can modulate the isotypic response of TNP-Ficoll-activated B ceils through an influence on the switching process. This has not been unequivocally proven, however. For instance, we cannot exclude the possibility that switches to Igh-),2a occur with equivalent frequency in the presence or absence of T cells but that IgG~a secretion may not occur without accessory T cell signals. We think this possibility unlikely because, first, it is difficult to reconcile a strong dependence of IgG2a secretion on T cells with the relationship that IgG2a production has with Igh-C gene order, and second, because some IgG2~ Ab secretion does occur in the absence of thymus-processed T cells. In addition, we cannot exclude the possibility that in the presence of T cells, a new set of TNP-specific B cell clones that requires T cell signals for activation express themselves. These T-dependent B cell clones may more easily switch into IgG2~ production than T-independent B cell clones.
We have here and elsewhere stressed the influence that Igh-C gene order has on the quantities of the various isotypes of Ab produced in the B cell response to TNP-Ficoll. Although another TI-2 antigen that stimulates the Lyb-3+5 ÷ B cell subpopulation, TNP-levan, has been shown to stimulate a similar isotypie response (7), the TI-2 antigen dextran, antigens such as TNP-Brucella abortus and TNP-LPS (which we would now designate as type 1 antigens), and classical T-dependent antigens can stimulate different isotypic responses (31, 36, 37; and Dr. Kathryn Stein, personal communication). Clearly there may be factors in addition to 5' to 3' Igh-C gene order that affect the representation of the various isotypes of Ab in B cell responses to antigens. The polyclonal activation signals associated with most type 1 antigens, signals from T cells, the subpopulation of B cells being stimulated, and the existence of memory cells through previous exposure to environmental antigens may all influence the isotypic repertoire of B cell clones responding to antigen. We propose that the isotype switching events that take place during the B cell response to TNPFicoll, in the absence of thymus-matured T cells, represent an intrinsic switching mechanism for IgG subclass genes in the Lyb-3+5 + B cell subpopulation. In this process, the order of Igh-C genes on the chromosome may play a considerable role in influencing the likelihood that a particular IgG gene product will be produced. Additional signals provided by T cells, macrophages, or polyclonal activators may modify this intrinsic isotypic response hierarchy.
In this report, we have examined the response of isotypes encoded by genes to the IgA-specific switching sites have been reported and the existence of class-specific switching enzymes has been proposed (11).
Although we have clearly shown that T cells can preferentially increase the amount of certain IgG subclasses of Ab produced to TNP-FicolI, and although we have shown that T cells may very likely do this by influencing the Igh-C gene switching process within TNP-Ficoll-responsive B cell clones, we have not addressed the specificity of the T cell responsible nor the mechanism by which T cells influence the switch to Ighy2b and Igh-72a genes. Experiments designed to study the specificity question will be presented elsewhere. With regard to the mechanism of T cell influence on IgG2a production, it is possible that T cells enhance isotype switching events by enhancing the proliferation of TNP-Ficoll-responsive B cell clones. In fact, previous data have suggested that the commencement of IgG synthesis after antigen or mitogen stimulation is accompanied by and may require B cell proliferation (38, 39) . As an alternative explanation, T cells signals may increase the production of an IgG-specific switching enzyme and thus mediate an increase in the frequency of relatively lowprobability rearrangements, e.g., the switch to the Igh-y2a gene. A thorough understanding of the mechanism of T cell enhancement of the switching process will undoubtedly be facilitated by an in vitro system in which switching events can be induced within a homogeneous population of B cells.
Summary
In the absence ofT cells, B cells were found to respond to the type 2 T-independent (TI-2) antigen, trinitrophenyl (TNP)-Fieoll, with a characteristic hierarchy of IgM and IgG subclass Ab production which directly correlated with 5' to 3' Igh-C gene order, i.e., IgM > IgG8 > IgGx > IgG2b > IgG2a. This was evident when immune serum Ab titers were analyzed, when in vitro secretion of antibody from immune cells was measured and when TNP-Ficoll-stimulated clones in a splenic focus assay were analyzed for isotype production. T cells were found to cause a preferential relative increase in the amount of IgG2a antibody produced to TNP-Ficoll. The T cell responsible was present in anti-IgM neonatally suppressed mice and was needed early in the response, i.e., on the day of immunization or earlier. T cells were found to increase the frequency of TNP-Ficoll-responsive B cell clones that produced IgG~ in the splenic focus assay. The great majority of these IgG~-positive clones also produced IgM and all or nearly all of the IgG isotypes whose genes are encoded 5' to the Igh72a gene. The data are discussed in terms to T cell enhancement of IgG~ Ab synthesis being mediated through T cell enhancement of the Igh-C gene switching mechanism within TNP-Ficoll-responsive B cell clones. Thus, isotypes encoded by genes on the 3' end of the Igh-7 gene complex, which in the absence of T cells have a low probability of being switched to, are the most influenced by T cell help.
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